Prot #NU 17H08: Phase I/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination with R-CHOP in a Cohort of Patients with DLBCL/tFL/ high grade B-NHL

Project: Research project

Project Details

StatusActive
Effective start/end date10/2/1810/2/21

Funding

  • Bristol-Myers Squibb Company (Prot #NU 17H08)